2′-3′-dideoxyadenosine | |
---|---|
Trade Name | |
Orphan Indication | Aquired immunodeficiency syndrome |
USA Market Approval | USA |
USA Designation Date | 1987-07-21 00:00:00 |
Sponsor | National Cancer Institute, Dct;NIH, Exec. Plaza N., Room 7-18;Bethesda, Maryland, 20892 |